Physician profile
James Patrick Tasto
NPI 1053454744
$9,747.48
in general payments reported to CMS, 2019-2025
12 companies · $814 in 2025
The $814 reported for 2025 was more than what 94% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988 · 2020: $3,347 · 2021: $891 · 2022: $2,239 · 2023: $653 · 2024: $816 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,393 · Gift: $652 · Education: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.84 |
| Gift | $651.98 |
| Education | $238.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Purelife, LLC | $2,940.00 | 2019-2024 | |
| Align Technology, INC. | $2,862.95 | 2020-2025 | Invisalign, Invisalign Go, Itero Element 5d Plus |
| Dentsply Sirona INC | $1,749.77 | 2019-2025 | Cerec Tessera, Suresmile, Orthophos E |
| Patterson Companies, INC. | $884.39 | 2021-2025 | |
| Straumann USA LLC | $569.97 | 2022-2025 | |
| Ultradent Products INC | $294.93 | 2024-2025 | Opalescence |
| Orapharma, A Division of Bausch Health US, LLC | $144.83 | 2019-2025 | Arestin, Ossix Plus |
| Biohorizons Implant Systems INC. | $111.50 | 2019-2021 | |
| Premier Dental Products Company | $71.00 | 2019 | |
| 3m Company | $58.86 | 2021-2023 | Filtek, 3m Filtek, Scotchbond Universal Plus |
| Si-Bone, INC. | $34.19 | 2022 | |
| Carestream Dental, LLC | $25.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tasto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.